Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
ExEm Foam
- Development stage
- Approved
- Lead developer
- Giskit MD
- Modality
- Implantable Hydrogels → Hydrogel Systems → Drug Delivery Systems, Small Molecules, Non-biodegradable Polymers → Polymer-based Nanoparticles → Nanoparticles → Drug Delivery Systems, Biodegradable Polymers → Polymer-based Nanoparticles → Nanoparticles → Drug Delivery Systems, Injectable Hydrogels → Hydrogel Systems → Drug Delivery Systems
- Administration
- Vaginal
01
Overview
ExEm Foam is an ultrasound contrast agent indicated for sonographic assessment of fallopian tube patency in women with known or suspected infertility. The product is supplied as a kit containing ExEm Gel (composed of glycerin and hydroxyethyl cellulose) and ExEm Water (purified water). When the two components are mixed, they form a stable, highly echogenic foam. During a Hysterosalpingo-Foam Sonography (HyFoam) procedure, the foam is infused into the uterine cavity and fallopian tubes, where its high echogenicity allows for clear visualization of tubal flow and patency using transvaginal ultrasound. It provides a less invasive alternative to traditional hysterosalpingography (HSG) or laparoscopy for the initial evaluation of tubal factor infertility.
- Brand names
- ExEm FoamExEm Foam Kit
- Other names
- HyFoamHysterosalpingo-Foam Sonography contrast
Beyond the preview
Go deeper on ExEm Foam.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on ExEm Foam.